Elevated soluble thrombomodulin is associated with organ failure and mortality in children with acute respiratory distress syndrome (ARDS): A prospective observational cohort study

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Orwoll, Benjamin E ^a,b   Spicer, Aaron C ^c   Zinter, Matt S ^a,b   Alkhouli, Mustafa F ^a   Khemani, Robinder G ^d   Flori, Heidi R ^b   Neuhaus, John M ^e   Calfee, Carolyn S ^e   Matthay, Michael A ^e   Sapru, Anil ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOLUBLE THROMBOMODULIN; THROMBOMODULIN; UNCLASSIFIED DRUG; THBD PROTEIN, HUMAN;

ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CHILD; CHILDHOOD MORTALITY; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM INJURY; FEMALE; HUMAN; INDIRECT LUNG INJURY; INTENSIVE CARE UNIT; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; ORGAN DYSFUNCTION SCORE; PEDIATRIC LOGISTIC ORGAN DYSFUNCTION SCORE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCHOOL CHILD; BLOOD; CLINICAL TRIAL; COMPLICATION; LUNG; METABOLISM; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; VASCULAR ENDOTHELIUM;

CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LUNG; LUNG INJURY; MALE; MULTIPLE ORGAN FAILURE; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; THROMBOMODULIN;

EID: 84949781723     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-1145-9     Document Type: Article

References (41)

1. Flori HR, Glidden DV, Rutherford GW, Matthay MA. Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality. Am J Respir Crit Care Med. 2005;171:995-1001.
2. Erickson S, Schibler A, Numa A, Nuthall G, Yung M, Pascoe E, et al. Acute lung injury in pediatric intensive care in Australia and New Zealand: a prospective, multicenter, observational study. Pediatr Crit Care Med. 2007;8:317-23.
3. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-49.
4. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 Pt 1):818-24.
5. Hoelz C, Negri EM, Lichtenfels AJ, Conceção GM, Barbas CS, Saldiva PH, et al. Morphometric differences in pulmonary lesions in primary and secondary ARDS. A preliminary study in autopsies. Pathol Res Pract. 2001;197:521-30.
6. Shaver CM, Bastarache JA. Clinical and biological heterogeneity in acute respiratory distress syndrome: direct versus indirect lung injury. Clin Chest Med. 2014;35:639-53.
7. Calfee CS, Janz DR, Bernard GR, May AK, Kangelaris KN, Matthay M a, et al. Distinct molecular phenotypes of direct versus indirect ARDS in single and multi-center studies. Chest J 2014:1539-1548.
8. Aird W. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Sepsis. 2003;101:3765-77.
9. Del Sorbo L, Slutsky AS. Acute respiratory distress syndrome and multiple organ failure. Curr Opin Crit Care. 2011;17:1-6.
10. Kawanami O, Jin E, Ghazizadeh M, Fujiwara M, Jiang L, Nagashima M, et al. Heterogeneous distribution of thrombomodulin and von Willebrand factor in endothelial cells in the human pulmonary microvessels. J Nippon Med Sch. 2000;67:118-25.
11. Conway EM. Thrombomodulin and its role in inflammation. Semin Immunopathol. 2012;34:107-25.
12. Martin FA, Murphy RP, Cummins PM. Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects. Am J Physiol Heart Circ Physiol. 2013;304:H1585-97.
13. Öhlin AK, Larsson K, Hansson M. Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma. J Thromb Haemost. 2005;3:976-82.
14. Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest. 1985;76:2178-81.
15. Boehme MWJ, Galle P, Stremmel W. Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals. Immunology. 2002;107:340-9.
16. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med. 2001;345:408-16.
17. Ikegami K, Suzuki Y, Yukioka T, Matsuda H, Shimazaki S. Endothelial cell injury, as quantified by the soluble thrombomodulin level, predicts sepsis/multiple organ dysfunction syndrome after blunt trauma. J Trauma. 1998;44:789-94. discussion 794-5.
18. Bouman AC, Cheung YW, Spronk HM, Schalkwijk CG, Ten Cate H, Ten Wolde M, et al. Biomarkers for post thrombotic syndrome: a case-control study. Thromb Res. 2014;134:369-75.
19. Lin S-M, Wang Y-M, Lin H-C, Lee K-Y, Huang C-D, Liu C-Y, et al. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis. Crit Care Med. 2008;36:683-9.
20. Boehme MW, Deng Y, Raeth U, Bierhaus A, Ziegler R, Stremmel W, et al. Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies. Immunology. 1996;87:134-40.
21. Strijbos MH, Rao C, Schmitz PIM, Kraan J, Lamers CH, Sleijfer S, et al. Correlation between circulating endothelial cell counts and plasma thrombomodulin levels as markers for endothelial damage. Thromb Haemost. 2008;100:642-7.
22. Ware LB, Fang X, Matthay MA. Protein C and thrombomodulin in human acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2003;285:L514-21.
23. McClintock D, Zhuo H, Wickersham N, Matthay MA, Ware LB. Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury. Crit Care. 2008;12:R41.
24. Agrawal A, Zhuo H, Brady S, Levitt J, Steingrub J, Siegel MD, et al. Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials. Am J Physiol Lung Cell Mol Physiol. 2012;303:L634-9.
25. Sapru A, Calfee CS, Liu KD, Kangelaris K, Hansen H, Pawlikowska L, Ware LB, Alkhouli MF, Abbot J, Matthay MA: Plasma soluble thrombomodulin levels are associated with mortality in the acute respiratory distress syndrome. Intensive Care Med 2015.
26. Thomas NJ, Shaffer ML, Willson DF, Shih M-C, Curley MAQ. Defining acute lung disease in children with the oxygenation saturation index. Pediatr Crit Care Med. 2010;11:12-7.
27. Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med. 1996;24:743-52.
28. Leteurtre S, Martinot A, Duhamel A, Proulx F, Grandbastien B, Cotting J, et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet. 2003;362:192-7.
29. Cuzick J. A Wilcoxon-type test for trend. Stat Med. 1985;4:87-90.
30. Menashi S, Aurousseau MH, Gozin D, Daffos F, D'Angelo A, Forestier F, et al. High levels of circulating thrombomodulin in human foetuses and children. Thromb Haemost. 1999;81:906-9.
31. Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007;71:1028-35.
32. Krafte-Jacobs B, Brilli R. Increased circulating thrombomodulin in children with septic shock. Crit Care Med. 1998;26:933-8.
33. Johansen ME, Johansson PI, Ostrowski SR, Bestle MH, Hein L, Jensen ALG, et al. Profound Endothelial Damage Predicts Impending Organ Failure and Death in Sepsis. Semin Thromb Hemost. 2015;1:16-25.
34. Rubin DB, Wiener-Kronish JP, Murray JF, Green DR, Turner J, Luce JM, et al. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest. 1990;86:474-80.
35. Ware LB, Eisner MD, Thompson BT, Parsons PE, Matthay MA. Significance of Von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med. 2004;170:766-72.
36. Flori HR, Ware LB, Milet M, Matthay MA. Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation. Pediatr Crit Care Med. 2007;8:96-101.
37. Calfee CS, Gallagher D, Abbott J, Thompson BT, Matthay MA. Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance. Crit Care Med. 2012;40:1731-7.
38. Hofstra J-JH, Juffermans NP, Schultz MJ, Zweers MM. Pulmonary coagulopathy as a new target in lung injury--a review of available pre-clinical models. Curr Med Chem. 2008;15:588-95.
39. Sapru A, Curley MAQ, Brady S, Matthay MA, Flori H. Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury. Intensive Care Med. 2010;36:157-63.
40. Ogawa Y, Yamakawa K, Ogura H, Kiguchi T, Mohri T, Nakamori Y, et al. Recombinant human soluble thrombomodulin improves mortality and respiratory dysfunction in patients with severe sepsis. J Trauma Acute Care Surg. 2012;72:1150-7.
41. Vincent J-L, Ramesh MK, Ernest D, LaRosa SP, Pachl J, Aikawa N, et al. A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med. 2013;41:2069-79.